Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Applied Nutrition flags full-year results ahead of expectations

Tue 19 Aug 2025 08:29

(Sharecast News) - Applied Nutrition said in an update on Tuesday that it expects full-year results to come in ahead of market expectations, with revenue and profit both posting strong double-digit growth. The London-listed sports nutrition, health and wellness group reported that revenue for the year ended 31 July rose 24% to about £107m, compared with £86m a year earlier, while adjusted EBITDA increased by around 19% from £26m.

Net cash at the year-end was also stronger than expected at about £18.5m, ahead of the £16.6m consensus forecast.

The company said the performance was driven by a strong second half, which contributed around £60m of sales, underpinned by its global growth strategy.

Looking ahead, Applied Nutrition said it expected revenue for the 2026 financial year to be above current consensus, which previously stood at £112.4m.

The firm said it remained confident that its B2B-focused model, broad product range and investment in new product development would continue to support growth and profitability.

"We are proud to report that we have exceeded the guidance we gave at our IPO, with our first full-year results expected to come in ahead of market expectations," said chief executive Thomas Ryder.

"Our focus and ambition remain as strong as ever - in delivering for our shareholders, customers and team - and we are excited about the opportunities we have in the pipeline for the year ahead."

The company said it expects to publish its full results on or around 10 November.

At 0931 BST, shares in Applied Nutrition were up 8.41% at 142.24p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Tue 15 Sep 2026 14:39
Aeorema Communications shares jump on guidance upgrade
(Sharecast News) - Shares in Aeorema Communications jumped on Tuesday after the AIM-listed strategic comms firm hiked its profit guidance for the full year following a strong start to the second half.
Tue 15 Sep 2026 14:14
Citi lifts price target on Vodafone, maintains 'neutral' rating
(Sharecast News) - Citi lifted its price target on Vodafone on Tuesday to 127p from 110p as it said scope for positive news was stopping it from taking a more cautious stance.
Tue 15 Sep 2026 13:12
MJ Gleeson swings to full-year loss, cuts dividend
(Sharecast News) - MJ Gleeson said on Tuesday that it swung to a full-year pre-tax loss in a 'subdued' market, as it took a hit from exceptional costs of £13.6m.
Tue 15 Sep 2026 12:42
Deutsche Bank upgrades Astrazeneca to 'hold'
(Sharecast News) - Deutsche Bank upgraded Astrazeneca from 'sell' to 'hold' on Tuesday and nudged its price target up from 11,500p to 11,700p, saying the risk‑reward scenario had shifted following last week's negative SERENA-4 readout and a period of underperformance against European large‑cap peers.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Awards

Award 1
Award 2
Award 3

Policies and important information

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Statutory and Regulatory disclosures | Whistleblowing programme

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026